Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Scheduling (national classification system) (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Committees and advisory bodies (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
185 result(s) found, displaying 101 to 125
-
Corporate reportsThe report card shows the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
-
Corporate reportsStatistical information for 1 July to 31 December 2019 in relation to our regulation of therapeutic goods
-
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
Corporate reportsThis report describes the first 12 months of the mandatory reporting scheme
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsThe Health Products Regulation Group has published a new regulatory science strategy
-
Corporate reportsOur plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
-
Corporate reportsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
Corporate reportsTGA instructions for disinfectant testing.
-
Corporate reportsTargets have been met for most measures under the six KPIs
-
Corporate reportsRegulatory Impact Self-Assessment Report
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
Corporate reportsThe TGA has conducted a safety review on coumarin in topical listed medicines
-
Corporate reportsOn Monday, 2 December 2019, a TGA Progress Report to the Senate Mesh Inquiry was tabled in the Senate
-
Corporate reportsFurther comments received on the consultation
-
Corporate reportsSubmissions received: Regulation of software, including Software as a Medical Device (SaMD).
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
Corporate reportsPublication of submissions to the public consultation paper Proposed changes to the classification of active implantable medical devices and their accessories
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for the year 2018-19
-
Corporate reportsPublication of submissions to the public consultation paper Potential reclassification of active medical devices for diagnosis and patient therapy
-
Corporate reportsPublication of submissions to the public consultation paper Proposed new classification rule for medical devices that administer medicines or biologicals by inhalation
-
Corporate reportsPublication of submissions to the public consultation paper Proposed changes to the classification of medical devices used in direct contact with the heart, central circulatory or central nervous systems
-
Corporate reportsPublication of submissions to the public consultation paper Proposed reclassification of spinal implantable medical devices
-
Corporate reportsThe 2018-19 Annual Performance Statistics Report is now available